ENO1 and central nervous system cancer: Among these, ENO1 was identified as the most significantly downregulated protein in the secretomes of both TMZ-shATG5 and TMZR-shATG5 cells (Fig. 1B), and its function had not been previously explored in the extracellular environment of gliomas.